medicare part d glp 1 coverage Spending on Ozempic and Other GLP-1s Is Skyrocketing Medicare GLP-1 Bridge Program: $50
Description
A new deal between the White House and pharmaceutical companies like Novo Nordisk and Eli Lilly is shaking things up.
Despite supply shortages, the GLP-1 drugs by the two companies saw their sales surge in the first quarter of the year, and competitors are still trying to catch up.
Mounjaro (tirzepatide) and Ozempic (semaglutide) are often praised on social media for helping people lose weight
At EllieMD, we are more than just a telehealth platform
